Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus II Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05470491
What this trial is testing

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Who this might be right for
HIVHematologic Malignancies
National Cancer Institute (NCI) 265
Not applicableStudy completedNCT07061912
What this trial is testing

Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the US

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 122
Testing effectiveness (Phase 2)Study completedNCT00967187
What this trial is testing

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

Who this might be right for
HIV Infections
Myrexis Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01146119
What this trial is testing

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00992433
What this trial is testing

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 192
Testing effectiveness (Phase 2)Study completedNCT02121756
What this trial is testing

Dipyridamole for Immune Activation in HIV

Who this might be right for
HIV Infection
Sharon Riddler 40
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00089492
What this trial is testing

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 64
Testing effectiveness (Phase 2)Study completedNCT00002419
What this trial is testing

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Who this might be right for
HIV Infections
Gilead Sciences 25
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00000644
What this trial is testing

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT01769456
What this trial is testing

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 78
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Not applicableStudy completedNCT00103896
What this trial is testing

Connect to Protect Partnerships for Youth Prevention Interventions: Phase II

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 16,706
Testing effectiveness (Phase 2)Study completedNCT00000940
What this trial is testing

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 121
Testing effectiveness (Phase 2)Study completedNCT04930744
What this trial is testing

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Who this might be right for
TuberculosisPulmonary TuberculosisHIV Coinfection
University of Massachusetts, Worcester 112
Testing effectiveness (Phase 2)Study completedNCT05330143
What this trial is testing

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

Who this might be right for
HIV-1-infectionHIV InfectionsPD-L1 Gene Mutation
Ascletis Pharmaceuticals Co., Ltd. 19
Testing effectiveness (Phase 2)Study completedNCT05065905
What this trial is testing

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

Who this might be right for
HIV CoinfectionAids/Hiv ProblemTuberculosis, Pulmonary+3 more
SPP Pharmaclon Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT02290041
What this trial is testing

Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response

Who this might be right for
Discordant Immunological Response in HIV Infected Subjects
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 5
Testing effectiveness (Phase 2)Study completedNCT01403051
What this trial is testing

High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 167
Next Page